Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BRIEF-‍Nanostring and NSABP Foundation enter into agreement to study immunophenotypes in colorectal cancer​

By: Reuters: Company News
* ‍Nanostring and NSABP foundation enter into agreement to study immunophenotypes in colorectal cancer​ Source text for Eikon: Further company coverage:
Related Stocks:
Nanostring Tech
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.